Efficacy of supplemental hemoadsorption therapy on severe and critical patients with COVID-19: an evidence-based analysis
Description
CONCLUSION: Given the better mortality outcomes, HAT confers clinical benefits to patients with severe COVID-19, which correlated with cytokine removal by HAT. Cytokine adsorption may not provide clinical benefits for patients with severe COVID-19
